Ascend Capital’s Imperva IMPV Stock Holding History
Bought
Maintained
Sold
Other funds holding IMPV
Ascend Capital's IMPV Position: Q3 2018 in Review
Ascend Capital reduced its Imperva (IMPV) stake by 7.3% in Q3 2018, selling an estimated $402K and leaving 105,998 shares worth $4.92M. The position accounts for 0.25% of the portfolio, ranked #100.
Ascend Capital first reported a position in IMPV in Q2 2018 and has held it in 2 quarters since. The position peaked at $5.52M in Q2 2018. 168 funds tracked by Wall St. Rank hold IMPV as of Q3 2018.
- Ascend Capital held 105,998 shares of Imperva worth $4.92M as of Q3 2018.
- Ascend Capital sold 8,301 Imperva shares in Q3 2018, an estimated $402K.
- Imperva made up 0.25% of Ascend Capital's portfolio in Q3 2018, its #100 holding.
- Ascend Capital first reported a position in Imperva in Q2 2018 and has held it in 2 quarters since.
- Ascend Capital's Imperva position peaked at $5.52M in Q2 2018.
- 168 funds tracked by Wall St. Rank held Imperva as of Q3 2018.
Based on Ascend Capital's 13F filing for Q3 2018, filed 13 Nov 2018.